Wed.Jun 29, 2022

article thumbnail

The Pathway to Ambulatory Care Pharmacy

Pharmacy Is Right For Me

There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! To highlight some of the more unique career settings in the industry, we’re introducing a new page on our website— Novel Pharmacy Practice Settings —where you can explore these unique career pathways. In addition to learning more about unique pathways on our new webpage, we’ll also be featuring pharmacists who work in these unique settings on our blog.

article thumbnail

Radius, Menarini Submit NDA for Elacestrant as Treatment of ER+/HER2- Breast Cancer

Pharmacy Times

As part of the submission, the companies have also requested priority review with the FDA for elacestrant in patients with ER+/HER2- advanced or metastatic breast cancer.

FDA 131
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

Approximately 75,000 enzymes are thought to exist in the human body as vital catalysts for biochemical reactions or conversions. For hundreds of years, we have found myriad uses for microbial enzymes in manufacturing – from food, drink, and household products to a range of industrial applications. The pharmaceutical industry often relies on enzymes to perform a process known as biocatalysis, which facilitates the cost-effective and sustainable production of small molecule drugs at scale.

article thumbnail

Study: COVID-19 Vaccination Not Associated With Increased Risk of Heart Attack, Stroke

Pharmacy Times

The study included the BNT162b2 and CoronaVac vaccines, which are the only COVID-19 vaccines authorized for emergency use in Hong Kong.

Vaccines 145
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

AI hiring levels in the pharmaceutical industry rose in May 2022

Pharmaceutical Technology

The proportion of pharmaceutical companies hiring for AI related positions kept relatively steady in May 2022 compared with the equivalent month last year, with 39.3% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 39% of companies who were hiring for AI related jobs a year ago but a decrease compared to the figure of 43.6% in April 2022.

article thumbnail

Study: Women Less Likely to Receive Timely Treatment for Heart Attacks

Pharmacy Times

Investigators also noted that Black, Hispanic, and Asian individuals were less likely than white individuals to undergo timely angiography and had minimal changes overtime.

123
123

More Trending

article thumbnail

Expert Discusses Pharmacist's Role in Contraception, What Reversal of Roe v. Wade Could Mean

Pharmacy Times

Elizabeth Ruzzo, PhD, founder and CEO of Adyn, discusses the impact of the reversal of Roe v. Wade and how it will affect pharmacies.

132
132
article thumbnail

Terumo and GenCure sign agreement for cell and gene therapies

Pharmaceutical Technology

Terumo Blood and Cell Technologies and BioBridge Global subsidiary, GenCure, have entered a new partnership agreement to expand and integrate cell and gene therapy manufacturing solutions. In a bid to meet the growing demand for automated and closed smart systems across the cell and gene therapy (CGT) industry, the companies entered the deal to merge technologies and capabilities.

105
105
article thumbnail

Tip of the Week: Proper, Comprehensive Training is Essential to Enhance Implementation of New Services

Pharmacy Times

Providing sufficient and comprehensive training about a new service could ensure both successful implementation and increased engagement of staff toward that intervention.

102
102
article thumbnail

Q&A With Anastasiia Kamenska, director of corporate strategy, Novartis

PharmExec

As director of corporate strategy for Novartis, Kamenska defines direction for the company’s overall enterprise. Here, she discusses how the pandemic and recent market events are shaping these strategies.

98
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

COVID-19 Affects Development of Medical Devices

Pharmacy Times

Companies, FDA caught unaware by surge in virus cases, leading to shortage of critical items.

FDA 130
article thumbnail

Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years

Pharmaceutical Technology

This year has already been eventful when it comes to the development of therapies for rare diseases. The US Food and Drug Administration (FDA) put a high-profile bluebird bio trial for sickle cell disease on partial clinical hold, and advisory panels deliberated over decisions involving gene therapies for amyotrophic lateral sclerosis (ALS), cerebral adrenoleukodystrophy (CALD), and beta-thalassemia.

article thumbnail

The Dawn of Scaleable Behavioral Diagnostics in Health Care

Pharmacy Times

Throughout the world, patients and health care professionals alike have become better acquainted with digital tools when face-to-face interactions became increasingly problematic.

94
article thumbnail

NHS App could offer video consultations by 2024

pharmaphorum

The NHS App will be updated over the next couple of years to include a series of new features, including the ability to offer remote video consultations between patients and GPs, according to the Department of Health and Social Care. The update to the app is part of a series of measures unveiled in the Plan for Digital Health and Social Care that describes how technologies will be used to “drive efficiency, free up hospital space and clinician time, and bust the Covid backlogs.” From

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

FDA Approves LungFit PH to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure

Pharmacy Times

The approval eliminates the need for traditional nitric oxide tanks in the hospital setting.

Hospitals 123
article thumbnail

Pfizer seeks to overturn three RSV vaccine patents held by GSK

pharmaphorum

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month, Pfizer filed a lawsuit (HP-2022-000016) in the Royal Courts of Justice in London, seeking to invalidate three GSK patients covering its RSVPreF3 shot, according to a report on the Law360.com website.

article thumbnail

Acupuncture May Reduce Chronic Tension-Type Headaches

Pharmacy Times

Patients recorded their symptoms and use of acute medications in a headache diary.

123
123
article thumbnail

The scientist's struggle: Lessons from the journey of mRNA pioneers Katalin Karikó and Drew Weissman

PharmaVoice

The two Penn Medicine researchers whose work brought the mRNA vaccines into COVID-19 fruition want to see the pharma world embrace early science.

article thumbnail

Reducing human error with better technology

European Pharmaceutical Review

Throughout a cleanroom’s life a variety of environmental and material samples are collected and tested to ensure the room remains… clean. However, with the sheer volume of samples collected, it is safe to assume human errors will occur over time. How can we minimise these challenges to data integrity? The post Reducing human error with better technology appeared first on European Pharmaceutical Review.

85
article thumbnail

Woman of the Week: Novartis' Marie-France Tschudin

PharmaVoice

How the chief commercial officer and president of innovative medicines international plans to fuel growth and productivity at the company.

98
article thumbnail

Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines

European Pharmaceutical Review

What are the key trends in the biologics or bioproduction industry? As the healthcare sector grows, there is a clear trend towards the expansion of biologic therapeutic drugs and vaccines like the one developed by Novavax. However, the design of these innovative biologics comes with intrinsic constraints. From our front row view of the pandemic these past three years, our mission necessitated that we leverage our years of vaccine expertise to help global health authorities address, control and e

article thumbnail

Clinical Overview: Cenobamate (Xcopri) for Partial-Onset Seizures

Pharmacy Times

Cenobamate is a once daily anti-epileptic medication with a recommended maintenance dose of 200 mg once daily that can be prescribed as monotherapy or adjunctive therapy.

65
article thumbnail

Fostering Patient Engagement with Portals

Pharmaceutical Commerce

Six engagement tips for companies to consider to improve patient use of portals.

98
article thumbnail

Modeling Study Finds COVID-19 Vaccines Prevented 20 Million Deaths Globally In First Year of Availability

Pharmacy Times

More than three-quarters of deaths averted were attributed to the direct protection against severe symptoms provided by vaccination, leading to lower mortality rates.

article thumbnail

Japan’s MHLW accepts GSK’s submission for shingles vaccine in adults

Pharmaceutical Technology

The Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted GlaxoSmithKline’s (GSK) regulatory application for recombinant, adjuvanted Zoster vaccine, Shingrix, for preventing shingles (herpes zoster) in at-risk adults of the age 18 years and above. The submission also comprises the use of the vaccine to prevent shingles in people with immunodeficiency or immunosuppression caused by known disease or treatment.

article thumbnail

Daily Medication Pearl: Semaglutide (Wegovy)

Pharmacy Times

Semaglutide (Wegovy) is indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients.

65
article thumbnail

Q&A With Natalie DiMambro, vice president, product commercialization and training at Within3

PharmExec

DiMambro discusses how companies can update their systems and strategies to collect data which ensures that marginalized groups and diverse voices are included.

59
article thumbnail

Is Your Pharmacy Marketing Aspirins Or Vitamins?

DiversifyRx

Distinguishing between these types of pharmacy marketing messaging is critical to successfully marketing your pharmacy and improving pharmacy profits. You’ll do whatever it takes to stop a throbbing, torturous headache. If you’re out of aspirin at 3 a.m. on a cold, snowy night, you’ll wrap up and go to a 24-hour store to get some aspirin, right?

article thumbnail

Kayla Dillon’s Testimonial: Seeking Efficiency with Coaching

The Happy PharmD

For many recent graduates like Kayla, getting started as a professional can be difficult. Because many graduates apply for a few positions, competition for job opportunities is usually fierce. Despite this, Kayla was able to start her career after securing a job in a retail pharmacy. However, despite enjoying some aspects of retail practice, such as counseling patients and administering vaccines, the pharmacy was understaffed, and work was stressful.

article thumbnail

Behind the Creative…Inspiring Award Winning Creative with Omair Ahmed

PharmExec

Nexus Pharmaceuticals' Chief Strategy Officer Omair Ahmed discusses their APEX-award winning EMERPHED™ campaign, which built on the ideas of simplification, safety and stability to enhance their hospital-delivered product and support their field sales reps.

article thumbnail

US panel backs Omicron-targeting vaccines for booster campaigns

pharmaphorum

Future booster campaigns against COVID-19 should include vaccines with a component targeting the Omicron variant of SARS-CoV-2, according to the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC). After hours of deliberation, the panellists voted by 19 to two in favour of using redesigned booster shots, rather than simply using the currently authorised vaccines – although there was broad acknowledgement that the decision comes on the back of inadequate data.

article thumbnail

Ready for Resilience: The Supply Chain Future

Pharmaceutical Commerce

Maria Whitman and Anshul Agarwal of ZS offer their perspectives on the current and future supply chain challenges facing the global biopharma industry.

52
article thumbnail

Learning and Development Is the Key to Compliance in Life Sciences

PharmExec

Employees must be able to retain information and remain engaged to keep pace with highly regulated industry.

52
article thumbnail

Daily OTC Pearl: Migraine Be KoooL

Pharmacy Times

Migraine Be KoooL is intended to provide relief from headaches, fever, muscle aches, sprains, and over-exertion.

65